# Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction

> **NCT01041586** · PHASE1 · COMPLETED · sponsor: **Uptake Medical Corp** · enrollment: 10 (actual)

## Conditions studied

- Emphysema
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DEVICE:** BTVA System

## Key facts

- **NCT ID:** NCT01041586
- **Lead sponsor:** Uptake Medical Corp
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-01
- **Final completion:** 2011-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01041586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01041586, "Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01041586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*